Telomeres: Cancer to human aging

Annual Review of Cell and Developmental Biology

Volumn 22, Issue , 2006, Pages 531-557

  Stewart, Sheila A ^a   Weinberg, Robert A ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Crisis; Senescence; Telomerase; Tumorigenesis

Indexed keywords

B RAF KINASE; DNA; DOUBLE STRANDED DNA; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN P16INK4A; PROTEIN P53; RETINOBLASTOMA PROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERE BINDING PROTEIN; TELOMERIC REPEAT BINDING FACTOR 2; TUMOR SUPPRESSOR PROTEIN;

AGING; CANCER; CELL IMMORTALIZATION; CELL PROLIFERATION; CHROMOSOMAL LOCALIZATION; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SENESCENCE; TELOMERE;

AGING; ANIMALS; CELL AGING; HUMANS; NEOPLASMS; TELOMERASE; TELOMERE; TELOMERE-BINDING PROTEINS;

MAMMALIA;

EID: 33751186139     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.22.010305.104518     Document Type: Review

References (143)

1. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, et al. 1992. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89:10114-18
2. Armitage P, Doll R. 1954. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 8:1-12
3. Armitage P, Doll R. 2004. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 91:1983-89
4. Artandi SE, Alson S, Tietze MK, Sharpless NE, Ye S, et al. 2002. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl. Acad. Sci. USA 99:8191-96
5. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, et al. 2000. Telomere dysfunction promotes nonreciprocal translocations and epithelial cancers in mice. Nature 406:641-45
6. Atkinson SP, Hoare SF, Glasspool RM, Keith WN. 2005. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res. 65:7585-90
7. Aviv A. 2004. Telomeres and human aging: facts and fibs. Sci. Aging. Knowl. Environ. 2004:pe43
8. Baumann P, Cech TR. 2001. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292:1171-75
9. Bechter OE, Zou Y, Shay JW, Wright WE. 2003. Homologous recombination in human telomerase-positive and ALT cells occurs with the same frequency. EMBO Rep. 4:1138-43
10. Ben-Porath I, Weinberg RA. 2004. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113:8-13
11. Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, Gilson E. 1997. Telomeric localization of TRF2, a novel human telobox protein. Nat. Genet. 17:236-39
12. Blackburn EH. 1991. Structure and function of telomeres. Nature 350:569-73
13. Blackburn EH. 2000. Telomere states and cell fates. Nature 408:53-56
14. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, et al. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34
15. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, et al. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-52
16. Boulikas T. 1996. Xeroderma pigmentosum and molecular cloning of DNA repair genes. AntiCancer Res. 16:693-708
17. Bradshaw PS, Stavropoulos DJ, Meyn MS. 2005. Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage. Nat. Genet. 37:193-97
18. Braig M, Lee S, Locldenkemper C, Rudolph C, Peters AH, et al. 2005. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436:660-65
19. Broccoli D, Smogorzewska A, Chong L, de Lange T. 1997. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 17:231-35
20. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. 1997. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3:1271-74
21. Campisi J. 1996. Replicative senescence: an old live's tale? Cell 84:497-500
22. Campisi J, Kim SH, Lim CS, Rubio M. 2001. Cellular senescence, cancer and aging: the telomere connection. Exp. Gerontol. 36:1619-37
23. Cesare AJ, Griffith JD. 2004. Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol. Cell Biol. 24:9948-57
24. Chang S, Multani AS, Cabrera NG, Naylor ML, Laud P, et al. 2004. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat. Genet. 36:877-82
25. Chang W, Dynek JN, Smith S. 2003. TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres. Genes Dev. 17:1328-33
26. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, et al. 2005. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436:725-30
27. Choi D, Whittier PS, Oshima J, Funk WD. 2001. Telomerase expression prevents replicative senescence but does not fully reset mRNA expression patterns in Werner syndrome cell strains. FASEB J. 15:1014-20
28. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, et al. 2005. Tumour biology: senescence in premalignant tumours. Nature 436:642
29. Crabbe L, Verdun RE, Haggblom CI, Karlseder J. 2004. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 306:1951-53
30. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, et al. 2003. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:194-98
31. de Lange T. 2005. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19:2100-10
32. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363-67
33. Doherty AJ, Jackson SP. 2001. DNA repair: how Ku makes ends meet. Curr. Biol. 11:R920-24
34. Dokal I. 2001. Dyskeratosis congenita. A disease of premature ageing. Lancet 358(Suppl.):S27
35. Dunham MA, Neumann AA, Fasching CL, Reddel RR. 2000. Telomere maintenance by recombination in human cells. Nat. Genet. 26:447-50
36. Dyer CA, Sinclair AJ. 1998. The premature ageing syndromes: insights into the ageing process. Age Ageing 27:71-80
37. Dynek JN, Smith S. 2004. Resolution of sister telomere association is required for progression through mitosis. Science 304:97-100
38. Effros RB. 2000. Telomeres and HIV disease. Microbes Infect. 2:69-76
39. Espejel S, Blasco MA. 2002. Identification of telomere-dependent "senescence-like" arrest in mouse embryonic fibroblasts. Exp. Cell Res. 276:242-48
40. Espejel S, Franco S, Rodriguez-Perales S, Bouffler SD, Cigudosa JC, Blasco MA. 2002. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 21:2207-19
41. Faragher RG, Kill IR, Hunter JA, Pope FM, Tannock C, Shall S. 1993. The gene responsible for Werner syndrome may be a cell division "counting" gene. Proc. Natl. Acad. Sci. USA 90:12030-34
42. Garcia-Cao M, O'Sullivan R, Peters AH, Jenuwein T, Blasco MA. 2004. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat. Genet. 36:94-99
43. Goytisolo FA, Samper E, Edmonson S, Taccioli GE, Blasco MA. 2001. The absence of the DNA-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol. Cell Biol. 21:3642-51
44. Greenberg RA, Chin L, Femino A, Lee KH, Gottlieb GJ, et al. 1999. Short dysfunctional telomeres impair tumorigenesis in the INK4a(δ2/3) cancer-prone mouse. Cell 97:515-25
45. Greider CW, Blackburn EH. 1996. Telomeres, telomerase and cancer. Sci. Am. 274:92-97
46. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, et al. 1999. Mammalian telomeres end in a large duplex loop. Cell 97:503-14
47. Hahn WC. 2005. Telomere and telomerase dynamics in human cells. Curr. Mol. Med. 5:227-31
48. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. 1999a. Creation of human tumor cells with defined genetic elements. Nature 400:464-68
49. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, et al. 2002. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell Biol. 22:2111-23
50. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, et al. 1999b. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5:1164-70
51. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70
52. Hayflick L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37:614-36
53. Hayflick L. 1976. The cell biology of human aging. N. Engl. J. Med. 295:1302-8
54. Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM. 2004. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21 (CIP1), but not p16 (INK4a). Mol. Cell 14:501-13
55. Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee HW, Blasco MA. 1999. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18:2950-60
56. Holt SE, Glinsky W, Ivanova AB, Glinsky GV. 1999. Resistance to apoptosis in human cells conferred by telomerase function and telomere stability. Mol. Carcinog. 25:241-48
57. Houghtaling BR, Cuttonaro L, Chang W, Smith S. 2004. A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr. Biol. 14:1621-31
58. Itahana K, Campisi J, Dimri GP. 2004. Mechanisms of cellular senescence in human and mouse cells. Biogerontology 5:1-10
59. Jaco I, Munoz P, Blasco MA. 2004. Role of human Ku86 in telomere length maintenance and telomere capping. Cancer Res. 64:7271-78
60. Jaco I, Munoz P, Goytisolo F, Wesoly J, Bailey S, et al. 2003. Role of mammalian Rad54 in telomere length maintenance. Mol. Cell Biol. 23:5572-80
61. Jiang WQ, Zhong ZH, Henson JD, Neumann AA, Chang AC, Reddel RR. 2005. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex. Mol. Cell Biol. 25:2708-21
62. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, et al. 1999. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 21:111-14
63. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. 1999. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283:1321-25
64. Karlseder J, Hoke K, Mirzoeva OK, Bakkenist C, Kastan MB, et al. 2004. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol. 2:E240
65. Karlseder J, Smogorzewska A, de Lange T. 2002. Senescence induced by altered telomere state, not telomere loss. Science 295:2446-49
66. Khanna KK, Jackson SP. 2001. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27:247-54
67. Kim SH, Kaminker P, Campisi J. 1999. TIN2, a new regulator of telomere length in human cells. Nat. Genet. 23:405-12
68. Land H, Parada LF, Weinberg RA. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602
69. Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA. 1998. Essential role of mouse telomerase in highly proliferative organs. Nature 392:569-74
70. Lehmann AR. 2003. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 85:1101-11
71. Li B, Oestreich S, de Lange T. 2000. Identification of human Rap1: implications for telomere evolution. Cell 101:471-83
72. Liu D, O'Connor MS, Qin J, Songyang Z. 2004a. Telosome, a mammalian telomere-assoicated complex formed by multiple telomeric proteins. J. Biol. Chem. 279:51338-42
73. Liu D, Safari A, O'Connor MS, Chan DW, Laegeler A, et al. 2004b. PTOP interacts with POT1 and regulates its localization to telomeres. Nat. Cell Biol. 6:673-80
74. Liu Y, Masson JY, Shah R, O'Regan P, West SC. 2004. RAD51C is required for Holliday junction processing in mammalian cells. Science 303:243-46
75. Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, et al. 2000. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol. Cell Biol. 20:3286-91
76. Londono-Vallejo JA, Der-Sarkissian H, Gazes L, Bacchetti S, Reddel RR. 2004. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res. 64:2324-27
77. - senescence. Cell 73:347-60
78. Martin GM, Sprague CA, Epstein CJ. 1970. Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab. Invest. 23:86-92
79. Maser RS, DePinho RA. 2002. Connecting chromosomes, crisis, and cancer. Science 297:565-69
80. Mason PJ, Wilson DB, Bessler M. 2005. Dyskeratosis congenita: a disease of dysfunctional telomere maintenance. Curr. Mol. Med. 5:159-70
81. Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, et al. 2005. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc. Natl. Acad. Sci. USA 102:8222-27
82. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, et al. 2003. Telomerase maintains telomere structure in normal human cells. Cell 114:241-53
83. McClintock B. 1941. The stability of broken ends of chromosomes in Zea mays. Genetics 26:234-82
84. Meyerson M, Counter CM, Ng Eaton E, Ellisen LW, Steiner P, et al. 1997. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-95
85. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. 2005. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436:720-24
86. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, et al. 1999. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21:115-18
87. Munoz P, Blanco R, Flores JM, Blasco MA. 2005. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer. Nat. Genet. 37:1063-71
88. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews AVH, et al. 1997. Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-59
89. Nakura J, Ye L, Morishima A, Kohara K, Miki. T. 2000. Helicases and aging. Cell Mol. Life Sci. 57:716-30
90. Nijjar T, Bassett E, Garbe J, Takenaka Y, Stampfer MR, et al. 2005. Accumulation and altered localization of telomere-associated protein TRF2 in immortally transformed and tumor-derived human breast cells. Oncogene 24:3369-76
91. Olovnikov AM. 1973. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41:181-90
92. Opresko PL, von Kobbe C, Laine JP, Harrigan J, Hickson ID, Bohr VA. 2002. Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J. Biol. Chem. 277:41110-19
93. Paradis V, Youssef N, Dargere D, Ba N, Bonvoust F, et al. 2001. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum. Pathol. 32:327-32
94. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J. 2003. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell Biol. 5:741-47
95. Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, et al. 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107:323-37
96. Ramirez RD, Morales CP, Herbert BS, Rohde JM, Passons C, et al. 2001. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15:398-403
97. Rheinwald JG, Hahn WC, Ramsey MR, Wu JY, Guo Z, et al. 2002. A two-stage, p16 (INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell Biol. 22:5157-72
98. Rubin H. 2002. The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat. Biotechnol. 20:675-81
99. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, et al. 1999. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96:701-12
100. Rudolph KL, Chang S, Millard M, Schreiber-Agus N, DePinho RA. 2000. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 287:1253-58
101. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. 1998. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat. Biotechnol. 16:743-47
102. Ruley HE, Fried M. 1983. Clustered illegitimate recombination events in mammalian cells involving very short sequence homologies. Nature 304:181-84
103. Samper E, Goytisolo FA, Slijepcevic P, van Buul PP, Blasco MA. 2000. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 1:244-52
104. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, et al. 2005. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436:1048-52
105. Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, et al. 2004. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 18:1251-62
106. Shay JW, Bacchetti S. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer 33:787-91
107. Shay JW, Wright WE. 2005. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26:867-74
108. Shay JW, Wright WE, Werbin H. 1991. Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta 1072:1-7
109. Sherr CJ, DePinho RA. 2000. Cellular senescence: mitotic clock or culture shock? Cell 102:407-10
110. Shiloh Y, Kastan MB. 2001. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 83:209-54
111. Smith S, de Lange T. 2000. Tankyrase promotes telomere elongation in human cells. Curr. Biol. 10:1299-302
112. Smith S, Giriat I, Schmitt A, de Lange T. 1998. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282:1484-87
113. Song K, Jung D, Jung Y, Lee SG, Lee I. 2000. Interaction of human Ku70 with TRF2. FEBS Lett. 481:81-85
114. Stansel RM, de Lange T, Griffith JD. 2001. T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J. 20:5532-40
115. Stavropoulos DJ, Bradshaw PS, Li X, Pasic I, Truong K, et al. 2002. The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum. Mol. Genet. 11:3135-44
116. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, et al. 2002. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc. Natl. Acad. Sci. USA 99:12606-11
117. Takai H, Smogorzewska A, de Lange T. 2003. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13:1549-56
118. Tanaka H, Mendonca MS, Bradshaw PS, Hoelz DJ, Malkas LH, et al. 2005. DNA damage-induced phosphorylation of the human telomere-associated protein TRF2. Proc. Natl. Acad. Sci. USA 102:15539-44
119. Tarsounas M, Munoz P, Claas A, Smiraldo PG, Pittman DL, et al. 2004. Telomere maintenance requires the RAD51D recombination/repair protein. Cell 117:337-47
120. Teixeira MT, Arneric M, Sperisen P, Lingner J. 2004. Telomere length homeostasis is achieved via a switch between telomerase-extendible and -nonextendible states. Cell 117:323-35
121. Tokutake Y, Matsumoto T, Watanabe T, Maeda S, Tahara H, et al. 1998. Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem. Biophys. Res. Commun. 247:765-72
122. Tommerup H, Dousmanis A, de Lange T. 1994. Unusual chromatin in human telomeres. Mol. Cell Biol. 14:5777-85
123. Varley H, Pickett HA, Foxon JL, Reddel RR, Royle NJ. 2002. Molecular characterization of intertelomere and intratelomere mutations in human ALT cells. Nat. Genet. 30:301-5
124. Vaziri H, Benchimol S. 1998. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8:279-82
125. Verdun RE, Crabbe L, Haggblom C, Karlseder J. 2005. Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol. Cell 20:551-61
126. Vijg J, Suh Y. 2005. Genetics of longevity and aging. Annu. Rev. Med. 56:193-212
127. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, et al. 2001a. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413:432-35
128. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I. 2004. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat. Genet. 36:447-49
129. Vulliamy TJ, Knight SW, Mason PJ, Dokal I. 2001b. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol. Dis. 27:353-57
130. Watson JD. 1972. Origin of concatemeric T7 DNA. Nat. New Biol. 239:197-201
131. Wei W, Hemmer RM, Sedivy JM. 2001. Role of p14 (ARF) in replicative and induced senescence of human fibroblasts. Mol. Cell Biol. 21:6748-57
132. Wong KK, Maser RS, Bachoo RM, Menon J, Carrasco DR, et al. 2003. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421:643-48
133. Wood RD. 1999. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie 81:39-44
134. Wright WE, Shay JW. 1992. The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol. 27:383-89
135. Wright WE, Shay JW. 2002. Historical claims and current interpretations of replicative aging. Nat. Biotechnol. 20:682-88
136. Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, et al. 1999. Human endothelial cell life extension by telomerase expression. J. Biol. Chem. 274:26141-48
137. Ye JZ, Hockemeyer D, Krutchinsky AN, Loayza D, Hooper SM, et al. 2004. POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev. 18:1649-54
138. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR. 1999. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59:4175-79
139. Zhang X, Mar V, Zhou W, Harrington L, Robinson MO. 1999. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Gene Dev. 13:2388-99
140. Zhong Z, Shine L, Kaplan S, de Lange T. 1992. A mammalian factor that binds telomeric TTAGGG repeats in vitro. Mol. Cell Biol. 12:4834-43
141. Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, de Lange T. 2003. ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol. Cell 12:1489-98
142. Zijlmans JM, Martens UM, Poon SS, Raap AK, Tanke HJ, et al. 1997. Telomeres in the mouse have large interchromosomal variations in the number of T2AG3 repeats. Proc. Natl. Acad. Sci. USA 94:7423-28
143. Zimonjic D, Brooks MW, Popescu N, Weinberg RA, Hahn WC. 2001. Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res. 61:8838-44